Cargando…

Comparative Antitumor Activity of 5‐Fluorouracil and 5′‐Deoxy‐5‐fluorouridine in Combination with Radiation Therapy in Mice Bearing Colon 26 Adcnocarcinoma

The present study compared the antitumor activities of chemotherapy with 5‐fluorouracil (5‐FU) and with its prodrug 5′‐deoxy‐5‐fluorouridine (5′‐DFUR) in combination with radiotherapy on a solid colon 26 adenocarcinoma in the mouse. A single administration of 5′‐DFUR immediately after local irradiat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishikawa, Tohru, Tanaka, Yutaka, Ishitsuka, Hideo, Ohkawa, Tomohiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1989
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917805/ https://www.ncbi.nlm.nih.gov/pubmed/2527217 http://dx.doi.org/10.1111/j.1349-7006.1989.tb01679.x

Ejemplares similares

Cytokines Induce Uridine Phosphorylase in Mouse Colon 26 Carcinoma Cells and Make the Cells More Susceptible to 5′‐Deoxy‐5‐fluorouridine
por: Eda, Hiroyuki, et al.
Publicado: (1993)

Comparative Antitumor Activity and Intestinal Toxicity of 5′‐Deoxy‐5‐fluorouridine and Its Prodrug Trimethoxybenzoyl‐5′‐deoxy‐5‐fluorocytidine
por: Ninomiya, Yasuyuki, et al.
Publicado: (1990)

Antitumor Effects of 5′‐Deoxy‐S‐fluorouridine in Combination with Recombinant Human Interleukin 2 on Murine Colon Carcinoma 26
por: Midoro, Katsuo, et al.
Publicado: (1997)

Enhanced Antitumor Effect of 5′‐Deoxy‐5‐fluorouridine by Oral Administration with l‐Cysteine
por: Iigo, Masaaki, et al.
Publicado: (1989)

Enhanced therapeutic efficacy of 5'deoxy-5-fluorouridine in 5-fluorouracil resistant head and neck tumours in relation to 5-fluorouracil metabolising enzymes.
por: Peters, G. J., et al.
Publicado: (1989)

Increased cytotoxicity and bystander effect of 5-fluorouracil and 5′-deoxy-5-fluorouridine in human colorectal cancer cells transfected with thymidine phosphorylase
por: Evrard, A, et al.
Publicado: (1999)

Enhancement of the Anti‐tumor Effect of 5′‐Deoxy‐5‐fluorouridine by Transfection of Thymidine Phosphorylase Gene into Human Colon Cancer Cells
por: Kanyama, Hiroki, et al.
Publicado: (1999)

Interferon-α Enhances 5′-Deoxy-5-Fluorouridine-Induced Apoptosis by ERK-Dependant Upregulation of Thymidine Phosphorylase
por: Zhu, Yike, et al.
Publicado: (2013)

The potential for oral combination chemotherapy of 5′-deoxy-5-fluorouridine, a 5-FU prodrug, and cyclophosphamide for metastatic breast cancer
por: Yoshimoto, M, et al.
Publicado: (2003)

Crucial roles of thymidine kinase 1 and deoxyUTPase in incorporating the antineoplastic nucleosides trifluridine and 2′-deoxy-5-fluorouridine into DNA
por: SAKAMOTO, KAZUKI, et al.
Publicado: (2015)

Combination chemotherapy of oral 5'-deoxy-5-fluorouridine and cisplatin in advanced gastric cancer: a phase II study.
por: Ahn, M. J., et al.
Publicado: (1998)

Optimal Treatment Regimens for 5′‐Deoxy‐5‐fluorouridine, with or without (E)‐5‐(2‐Bromovinyl)‐2′‐deoxyuridine, against Various Tumors in Mice
por: Iigo, Masaaki, et al.
Publicado: (1990)

Effects of Sex Steroids and Growth Factors on Invasive Activity and 5′‐Deoxy‐5‐fluorouridine Sensitivity in Ovarian Adenocarcinoma OMC‐3 Cells
por: Ueda, Masatsugu, et al.
Publicado: (1998)

Increased sensitivity to the prodrug 5'-deoxy-5-fluorouridine and modulation of 5-fluoro-2'-deoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylase.
por: Patterson, A. V., et al.
Publicado: (1995)

5′‐Deoxy‐S‐fluorouridine Increases Daunorubicin Uptake in Multidrug‐resistant Cells and Its Activity Is Related with P‐gp 170 Expression
por: van der Heyden, Sylke, et al.
Publicado: (1994)

Optimized 5-Fluorouridine Prodrug for Co-Loading with Doxorubicin in Clinically Relevant Liposomes
por: Wu, Debra, et al.
Publicado: (2021)

Liposomal simvastatin sensitizes C26 murine colon carcinoma to the antitumor effects of liposomal 5‐fluorouracil in vivo
por: Luput, Lavinia, et al.
Publicado: (2020)

Dye label interference with RNA modification reveals 5-fluorouridine as non-covalent inhibitor
por: Spenkuch, Felix, et al.
Publicado: (2014)

Translational readthrough of nonsense mutant TP53 by mRNA incorporation of 5-Fluorouridine
por: Palomar-Siles, Mireia, et al.
Publicado: (2022)

Pharmacokinetic Modulation of Plasma 5‐Fluorouracil Concentrations to Potentiate the Antitumor Activity of Continuous Venous Infusion of 5‐Fluorouracil
por: Fujii, Setsuro, et al.
Publicado: (1989)

In vitro additive antitumor effects of dimethoxycurcumin and 5‐fluorouracil in colon cancer cells
por: Zhao, Huiying, et al.
Publicado: (2017)

5-Fluorouracil Treatment of CT26 Colon Cancer Is Compromised by Combined Therapy with IMMODIN
por: Demeckova, Vlasta, et al.
Publicado: (2022)

Differential Neuroprotective Effects of 5′-Deoxy-5′-Methylthioadenosine
por: Moreno, Beatriz, et al.
Publicado: (2014)

Synergistic Antitumor Effect of Dichloroacetate in Combination with 5-Fluorouracil in Colorectal Cancer
por: Tong, Jingtao, et al.
Publicado: (2011)

Pharmacokinetic properties and antitumor efficacy of the 5-fluorouracil loaded PEG-hydrogel
por: Yi, Hee, et al.
Publicado: (2010)

The effect of microneedles on the skin permeability and antitumor activity of topical 5-fluorouracil
por: Naguib, Youssef W., et al.
Publicado: (2014)

Synergistic antitumor effect of puerarin combined with 5-fluorouracil on gastric carcinoma
por: GUO, XU-FENG, et al.
Publicado: (2015)

A Novel Class of Antitumor Prodrug, 1‐(2′‐Oxopropyl)‐5‐fluorouracil (OFU001), That Releases 5‐Fluorouracil upon Hypoxic Irradiation
por: Shibamoto, Yuta, et al.
Publicado: (2000)

An Expeditious Total Synthesis of 5′-Deoxy-toyocamycin and 5′-Deoxysangivamycin
por: Dong, Xiangyou, et al.
Publicado: (2019)

Antitumor Activity of BOF‐A2, a New 5‐Fluorouracil Derivative
por: Fujii, Setsuro, et al.
Publicado: (1989)

Schedule-dependent antitumor effects of 5-fluorouracil combined with sorafenib in hepatocellular carcinoma
por: Deng, Lifen, et al.
Publicado: (2013)

Synthesis and Antitumor Activity of Amino Acid Ester Derivatives Containing 5-Fluorouracil
por: Xiong, Jing, et al.
Publicado: (2009)

Repeated cycles of 5-fluorouracil chemotherapy impaired anti-tumor functions of cytotoxic T cells in a CT26 tumor-bearing mouse model
por: Wu, Yanhong, et al.
Publicado: (2016)

Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon
por: Wu, Pingping, et al.
Publicado: (2020)

BH3 profiling discriminates the anti-apoptotic status of 5-fluorouracil-resistant colon cancer cells
por: Ishikawa, Kazuma, et al.
Publicado: (2019)

Molecular Insights on the Cyclic Peptide Nanotube-Mediated Transportation of Antitumor Drug 5-Fluorouracil
por: Liu, Huifang, et al.
Publicado: (2010)

Effects of the Plasma Concentration of 5‐Fluorouracil and the Duration of Continuous Venous Infusion of 5‐Fluorouracil with an Inhibitor of 5‐Fluorouracil Degradation on Yoshida Sarcomas in Rats
por: Fujii, Setsuro, et al.
Publicado: (1989)

Correlation between 5-fluorouracil metabolism and treatment response in two variants of C26 murine colon carcinoma
por: Kamm, Y J L, et al.
Publicado: (2003)

The c-MYC-ABCB5 axis plays a pivotal role in 5-fluorouracil resistance in human colon cancer cells
por: Kugimiya, Naruji, et al.
Publicado: (2015)

Efficacy of Topical 5% 5-Fluorouracil with Needling versus 5% 5-Fluorouracil Alone in Stable Vitiligo: A Randomized Controlled Study
por: Zahra, Fatima T., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j9f7lfi9m5up1l551ckimev12t